Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
8th Floor
Boston, MA 02210
April 29, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jordan Nimitz
| Re: | Ginkgo Bioworks Holdings, Inc. |
Registration Statement on Form S-1 (File No. 333-264129)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement, as amended, referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on May 3, 2022, or as soon as possible thereafter. The Company hereby authorizes Marko Zatylny of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please contact Marko Zatylny (marko.zatylny@ropesgray.com) / telephone: (617) 951-7980 of Ropes & Gray LLP as soon as the registration statement has been declared effective.
[Signature page follows]
| Very truly yours, | ||
| GINKGO BIOWORKS HOLDINGS, INC. | ||
| By: | /s/ Mark Dmytruk | |
| Name: | Mark Dmytruk | |
| Title: | Chief Financial Officer | |
[Signature Page to Acceleration Request]
